Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Johnson & Johnson (J&J) has provided and update regarding a pause of use of its COVID-19 vaccine. Earlier this week (as reported on April 15, 2021), the US Food and Drug Administration (FDA) and the US Centers for Disease Control and...

Patrizia Cavazzoni, M.D., has been appointed as Director of the US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER). She has served as Acting Director for the past year. She succeeds Janet Woodcock, M.D., now Acting...

Sanofi plans to invest EUR 400 million ($477 million) over five years to create a vaccine-production site in Singapore. In partnership with the Singapore Economic Development Board, the new site will mainly supply the Asian region and complement...

Servier, a Paris-based pharmaceutical company, has acquired the commercial, clinical, and research-stage oncology portfolio of Agios Pharmaceuticals, a Cambridge, Massachusetts-based pharmaceutical company, for up to $2 billion plus royalties....

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle, Washington-based biopharmaceutical developing small-molecule therapies, in a $721-million deal ($55 million upfront and future contingent milestone payments potentially worth up to an...

The European Medicines Agency has approved facilities and/or facility expansions in the European Union for COVID-19 vaccines from Pfizer/BioNTech, Moderna, and AstraZeneca. Pfizer/BioNTech A new facility at BioNTech’s site in Marburg, Germany was...